Draft Guidances Relating to the Development of Biosimilar Products; Public Hearing; Request for Comments

RIN

—

Last modified

Jun 27, 2012

Comment window

closed 5177d ago

American Pharmacists Association (APhA) filings

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between May 30, 2012 and May 30, 2012. 10 other organizations filed here. The comment window closed 5177d ago.

What American Pharmacists Association (APhA) filed (1)

May 30, 2012· American Pharmacists Association (APhA), et al - Comment· FDA-2011-D-0618-0065

Attached please find comments submitted by the following: Marcie Bough, PharmD Senior Director, Government Affairs American Pharmacists Association Kevin N. Nicholson, R.Ph., J.D. Vice President, Pharmacy Advisor Government Affairs and Public Policy National Association of Chain Drug Stores Ronna Hauser, Pharm.D. Vice President, Policy and Regulatory Affairs National Community Pharmacists Association

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (10)

See everyone who commented →

American Pharmacists Association (APhA)THIS ORG
1 filing · confidence 97%
Pharmaceutical Care Management Associationtrade assoc.
2 filings · confidence 85%
American Academy of Dermatology Associationtrade assoc.
1 filing · confidence 85%
American Intellectual Property Law Associationtrade assoc.
1 filing · confidence 85%
American Society of Clinical Oncologytrade assoc.
1 filing · confidence 85%
Biotechnology Information Institutetrade assoc.
1 filing · confidence 85%
Eli Lilly and Companyunverified attribution
1 filing · confidence 70%
Generic Pharmaceutical Associationtrade assoc.
1 filing · confidence 85%
Immune Deficiency Foundation (IDF) - Submission of Informationtrade assoc.
1 filing · confidence 85%
Janssen Research Development LLCunverified attribution
1 filing · confidence 70%
National Patient Advocate Foundationtrade assoc.
1 filing · confidence 85%